Article Details
Retrieved on: 2025-05-09 19:25:38
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Humacyte, Inc.'s advancements in regenerative medicine through bioengineered tissues, focusing on their ATEV technology, which has FDA approval for vascular trauma and other applications in clinical trials. Tags like "Food and Drug Administration" and "Regenerative Medicine Advanced Therapy" highlight regulatory and therapy aspects.
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here